Why mRNA Lipid Nanoparticles Need Cold Chains

为何mRNA脂质纳米颗粒需冷链运输

课文音频

可先听下面的整段朗读；需要逐句点读时，请打开阅读器，体验会更顺手。

课文

mRNA vaccines rely on fragile genetic molecules that degrade quickly at room temperature.

mRNA疫苗依赖易降解的遗传物质，室温下极易失活。
Scientists package mRNA inside tiny fat-based carriers called lipid nanoparticles, or LNPs.

科学家将mRNA封装在名为脂质纳米颗粒（LNP）的微小脂肪载体中。
These LNPs protect the mRNA like a bubble wrap during its journey into human cells.

这些LNP像气泡膜一样，在mRNA进入人体细胞的过程中为其提供保护。
But heat makes the lipids wobble, causing the particles to leak or clump together.

但高温会使脂质分子晃动，导致颗粒泄漏或聚集。
Even brief exposure above –20°C can reduce vaccine potency by over 30% in 48 hours.

即使短暂暴露于–20°C以上环境，48小时内疫苗效力也可能下降超30%。
That is why ultra-cold freezers and dry ice are essential for global distribution.

因此，超低温冰箱和干冰对全球分发至关重要。
New research focuses on adding sugar-like stabilizers to help LNPs survive warmer conditions.

最新研究聚焦于添加糖类稳定剂，以提升LNP在较高温度下的耐受性。
Some next-generation formulations now stay stable for weeks at refrigerator temperatures.

部分新一代制剂现已可在冰箱温度下保持数周稳定性。
This improvement could expand vaccine access in remote or low-resource regions.

这一改进有望扩大疫苗在偏远或资源匮乏地区的可及性。
Understanding LNP stability helps us appreciate both biotech innovation and logistics science.

理解LNP稳定性，有助于我们同时认识生物技术创新与物流科学的价值。